
WB analysis of human heart tissue using GTX47102 SLC6A2 antibody at 0.2-1μg/ml.
SLC6A2 antibody, Internal
GTX47102
ApplicationsWestern Blot
Product group Antibodies
ReactivityHuman
TargetSLC6A2
Overview
- SupplierGeneTex
- Product NameSLC6A2 antibody, Internal
- Delivery Days Customer9
- Application Supplier NoteWB: 0.2-2.5 ug/ml. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
- ApplicationsWestern Blot
- CertificationResearch Use Only
- ClonalityPolyclonal
- Concentration0.5-1 mg/ml
- ConjugateUnconjugated
- Gene ID6530
- Target nameSLC6A2
- Target descriptionsolute carrier family 6 member 2
- Target synonymsNAT1, NET, NET1, SLC6A5, sodium-dependent noradrenaline transporter, neurotransmitter transporter, norepinephrine transporter, solute carrier family 6 (neurotransmitter transporter), member 2, solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2, solute carrier family 6 member 5
- HostRabbit
- IsotypeIgG
- Protein IDP23975
- Protein NameSodium-dependent noradrenaline transporter
- Scientific DescriptionThis gene encodes a member of the sodium:neurotransmitter symporter family. This member is a multi-pass membrane protein, which is responsible for reuptake of norepinephrine into presynaptic nerve terminals and is a regulator of norepinephrine homeostasis. Mutations in this gene cause orthostatic intolerance, a syndrome characterized by lightheadedness, fatigue, altered mentation and syncope. Alternatively spliced transcript variants encoding different isoforms have been identified in this gene.[provided by RefSeq, Feb 2010]
- ReactivityHuman
- Storage Instruction-20°C or -80°C,2°C to 8°C
- UNSPSC41116161
References
- Venlafaxine antagonizes the noradrenaline-promoted colon cancer progression by inhibiting the norepinephrine transporter.Read this paper
- Norepinephrine transporter promotes the invasion of human colon cancer cells. Zhang H et al., 2020 Jan, Oncol LettRead this paper








